ClassID:

21647

A61K2300/00 - page 32 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#9301
20110086825
2011-04-14

Therapeutic vaginal emollient

#9302
20110086818
2011-04-14

METHODS, COMPOSITIONS, AND KITS FOR TREATING PAIN AND PRURITUS

#9303
20110086807
2011-04-14

Fibromodulin formulation for reducing corneal scarring

#9304
20110086802
2011-04-14

METHODS TO INCREASE PERMEABILITY OF CORNEAL EPITHELIUM AND DESTABILIZE STROMAL COLLAGEN FIBRIL NETWORK

#9305
20110086135
2011-04-14

Crystalloid electrolyte water formulation

#9306
20110086119
2011-04-14

Preparation for the relief of disease

#9307
20110086114
2011-04-14

Nasal composition

#9308
20110086113
2011-04-14

CANNABINOIDS IN COMBINATION WITH NON-CANNABINOID CHEMOTHERAPEUTIC AGENTS (E.G. SERM OR ALKYLATING AGENTS)

#9309
20110086112
2011-04-14

Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using same

#9310
20110086111
2011-04-14

Polymeric systems for the delivery of anticancer drugs

#9311
20110086109
2011-04-14

Low ether compositions and delivery apparatus

#9312
20110086108
2011-04-14

Dissolving powders that can be mixed with water and used as an oral rinse

#9313
20110086101
2011-04-14

DispersinB™, 5-fluorouracil, deoxyribonuclease I and proteinase K-based antibiofilm compositions and uses thereof

#9314
20110086094
2011-04-14

Capsule for the prevention of cardiovascular diseases

#9315
20110086093
2011-04-14

METHOD FOR INCREASING LACTOSE TOLERANCE IN MAMMALS EXHIBITING LACTOSE INTOLERANCE

#9316
20110086088
2011-04-14

Compositions and methods for treatment of mammalian skin

#9317
20110086074
2011-04-14

COMBINATIONS OF NIACIN AND AN OXICAM

#9318
20110086068
2011-04-14

Compositions and methods for tissue engineering, tissue regeneration and wound healing

#9319
20110086044
2011-04-14

Compositions and Methods to Inhibit HPV Infection

#9320
20110086040
2011-04-14

METHOD OF TREATING HEMOLYTIC DISEASE

#9321
20110086031
2011-04-14

Inhibition of the activity of the capsaicin receptor in the treatment of type 1 diabetes, type 2 diabetes, impaired glucose tolerance or insulin resistance

#9322
20110086025
2011-04-14

Combination Therapy of a Type II Anti-CD20 Antibody with an Anti-BCL-2 Active Agent

#9323
20110086023
2011-04-14

COMBINATION ANTIHISTAMINE MEDICATION

#9324
20110086020
2011-04-14

Agent exhibiting immunoregulatory properties and the use thereof for treating autoimmune diseases

#9325
20110086018
2011-04-14

Proteinases destroy cancer tumor's solid structure and kill cancer cells locally

#9326
20110086017
2011-04-14

Medical Food composition and methods for management of inflammatory processes in mammals

#9327
20110086011
2011-04-14

Prevention or treatment of immune-relevant disease by modification of microfloral populations

#9328
20110086008
2011-04-14

Composition and method for the repair and regeneration of cartilage and other tissues

#9329
20110086005
2011-04-14

MODULATING INTERSTITIAL PRESSURE AND ONCOLYTIC VIRAL DELIVERY AND DISTRIBUTION

#9330
20110086004
2011-04-14

METHODS OF TREATING CANCER USING IL-21 AND MONOCLONAL ANTIBODY THERAPY

#9331
20110085986
2011-04-14

Diagnosis and treatment of epithelial cancers using labeled/conjugated progastrin peptides

#9332
20110085968
2011-04-14

ARTICLES COMPRISING NANO-MATERIALS FOR GEOMETRY-GUIDED STEM CELL DIFFERENTIATION AND ENHANCED BONE GROWTH

#9333
20110083987
2011-04-14

Methods and compositions for tissue regeneration

#9334
20110083692
2011-04-14

METHOD AND APPARATUS FOR IMPROVING THE APPEARANCE OF NAILS AFFECTED BY ONYCHOMYCOSIS THROUGH THE TOPICAL APPLICATION OF HIGHLY CONCENTRATED OR SUPERSATURATED BORIC ACID

#9335
20110083201
2011-04-07

COMPOSITIONS FOR AND METHODS OF GRAZYME B INHIBITION

#9336
20110082482
2011-04-07

Materials and methods for nerve repair

#9337
20110082448
2011-04-07

Pharmaceutical Compositions

#9338
20110082407
2011-04-07

Combination Therapies for the Treatment of Obesity

#9339
20110082287
2011-04-07

Hepatitis C virus codon optimized non-structural NS3/4A fusion gene

#9340
20110082193
2011-04-07

TAXANE DERIVATIVE CONTAINING PHARMACEUTICAL COMPOSITION WITH IMPROVED THERAPEUTIC EFFICACY

#9341
20110082129
2011-04-07

Organic compounds

#9342
20110082124
2011-04-07

DETERGENT COMPOSITIONS FOR TREATMENT OF LIPOMAS AND OTHER CONDITIONS

#9343
20110082119
2011-04-07

PROPHYLACTIC/AMELIORATING OR THERAPEUTIC AGENT FOR NON-ALCOHOLIC STEATOHEPATITIS

#9344
20110082114
2011-04-07

Methods of Treating Aneurysmal Dilatation, Blood Vessel Wall Weakness and Specifically Abdominal Aortic and Thoracic Aneurysm Using Matrix Metalloprotease-2 Inhibitors

#9345
20110082102
2011-04-07

USE OF PREBIOTIC GALACTO-OLIGOSACCHARIDES IN THE TREATMENT OF INTESTINAL INFLAMMATION

#9346
20110082101
2011-04-07

COMBINATIONS COMPRISING EPOTHILONES AND ANTI-METABOLITES

#9347
20110082097
2011-04-07

Amino acid composition for improving glucose tolerance

#9348
20110082086
2011-04-07

MEDICAMENT FOR USE IN CONNECTION WITH CARTILAGE IMPAIRMENT

#9349
20110082084
2011-04-07

METHODS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE

#9350
20110082070
2011-04-07

Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency

#9351
20110081434
2011-04-07

Extract of and novel use thereof in treating respiratory disease

#9352
20110081433
2011-04-07

Compositions comprising an anti-inflammatory blend

#9353
20110081432
2011-04-07

Extracts of

#9354
20110081427
2011-04-07

Nitroxyl Progenitors in the Treatment of Heart Failure

#9355
20110081419
2011-04-07

Ion exchange resin treated to control swelling

#9356
20110081411
2011-04-07

Orally administered corticosteroid compositions

#9357
20110081405
2011-04-07

Zeolite Formulation And Use Thereof For The Prevention And Therapy Of Diseases Caused By Infections With Herpes Simplex Virus Type 1 And Type 2

#9358
20110081385
2011-04-07

Compositions and Methods for Sleep Regulation

#9359
20110081384
2011-04-07

Methods of wound care and treatment

#9360
20110081381
2011-04-07

Hepatitis C virus codon optimized non-structural NS3/4A fusion gene

#9361
20110081359
2011-04-07

Alpha 5 beta 1 and its ability to regulate the cell survival pathway

#9362
20110081356
2011-04-07

Anti-cancer drug

#9363
20110081354
2011-04-07

Anti-CTLA-4 antibodies with reduced blocking of binding of CTLA-4 to B7 and uses thereof

#9364
20110081334
2011-04-07

C1-inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis

#9365
20110081324
2011-04-07

Collagen peptide conjugates and uses therefor

#9366
20110081313
2011-04-07

MECHANISM OF ACTION OF PRIMARY CELL DERIVED BIOLOGIC

#9367
20110081312
2011-04-07

3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)

#9368
20110081308
2011-04-07

Extracts of

#9369
20110081304
2011-04-07

Extracts of

#9370
20110081301
2011-04-07

Pharmaceutical aerosol formulations of formoterol and beclometasone dipropionate

#9371
20110077581
2011-03-31

TARGETED CELLULAR DELIVERY OF NANOPARTICLES

#9372
20110077572
2011-03-31

Medical Equipment and Products using Chlorine, Hydrogen Peroxide, and Anti-Viral, Anti-Bacterial, Anti-Fungal, Agents, usage Method Improvements Dread Disease Cures, Remissions, and Anti-Infective Treatment Measures, Disease Treatment and Prevention System

#9373
20110077402
2011-03-31

ADMINISTRATION OF DIPEPTIDYL PEPTIDASE INHIBITORS

#9374
20110077303
2011-03-31

Increasing glutathione levels for therapy

#9375
20110077287
2011-03-31

PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED MRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS

#9376
20110077281
2011-03-31

Formulations comprising triptan compounds

#9377
20110077276
2011-03-31

Methods and Compositions for Reduction of Side Effects of Therapeutic Treatments

#9378
20110077275
2011-03-31

ANTIOXIDANT COMPOSITIONS FOR SOFT ORAL TISSUE AND METHODS OF FORMULATION AND USE THEREOF

#9379
20110077263
2011-03-31

Methods and Compositions of Toll-Like Receptor (TLR) Agonists

#9380
20110077260
2011-03-31

METHODS, COMPOSITIONS, AND KITS FOR ORGAN PROTECTION DURING SYSTEMIC ANTICANCER THERAPY

#9381
20110077259
2011-03-31

Compositions and methods for treating and preventing dermatoses

#9382
20110077258
2011-03-31

Treatment of malaria

#9383
20110077232
2011-03-31

COMPOSITIONS COMPRISING ATORVASTATIN 4-(NITROOXY) BUTYL ESTER AND A HYPOLIPIDEMIC DRUG

#9384
20110077222
2011-03-31

Sustained-Release Opiate and Opiate Derivative Compositions

#9385
20110077219
2011-03-31

Ophthalmic pharmaceutical compositions based on amino acids and sodium hyaluronate

#9386
20110077217
2011-03-31

SELECTIVELY DEPOLYMERIZED GALACTOMANNAN POLYSACCHARIDE

#9387
20110077212
2011-03-31

THERAPEUTIC USES OF SGLT2 INHIBITORS

#9388
20110077201
2011-03-31

High affinity VEGF-receptor antagonists

#9389
20110077200
2011-03-31

COMBINATION THERAPY USING LOW-DOSE DOXEPIN FOR THE IMPROVEMENT OF SLEEP

#9390
20110077198
2011-03-31

COMPOSITIONS AND METHODS FOR INHIBITING THE ACTIVATION OF DSRNA-DEPENDENT PROTEIN KINASE AND TUMOR GROWTH INHIBITION

#9391
20110077194
2011-03-31

Method for Treating or Preventing a Functional Vitamin B12 Deficiency in an Individual and to Medical Compositions for Use in Said Method

#9392
20110077193
2011-03-31

Artemisinin derivatives with natural amino acids, peptides, and amino sugars for the treatment of infection and topical condition in mammals

#9393
20110077189
2011-03-31

COMPOSITION FOR STIMULATING NATURAL KILLER CELL ACTIVITY

#9394
20110076385
2011-03-31

Ion exchange resin treated to control swelling

#9395
20110076347
2011-03-31

Molecules interfering with binding of calbindin to inositol monophosphatase for the treatment of mood disorders

#9396
20110076346
2011-03-31

Compositions from

#9397
20110076345
2011-03-31

Herbal formulation for the treatment of bone fractures and osseous defects

#9398
20110076343
2011-03-31

Multiple myeloma treatments

#9399
20110076342
2011-03-31

Cell proliferation reducing cancer specific PCNA peptides

#9400
20110076341
2011-03-31

TRACE ELEMENTS

#9401
20110076339
2011-03-31

Colon Cleansing Method and Kit

#9402
20110076338
2011-03-31

Composition for Skin Protection and Methods of Making Same

#9403
20110076327
2011-03-31

Herbal pain killer compositions

#9404
20110076324
2011-03-31

Use of Histamine H4 antagonist for the treatment of post-operative adhesions

#9405
20110076308
2011-03-31

Micelle encapsulation of therapeutic agents

#9406
20110076278
2011-03-31

Modulators of Hypoxia Inducible Factor-1 and Related Uses for the Treatment of Ocular Disorders

#9407
20110076271
2011-03-31

DIAGNOSTIC METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER

#9408
20110076266
2011-03-31

Synergistic pharmaceutical composition useful for inhibiting corneal and retinal neovascularization (angiogenesis), and in other organs, in a human being or animals

#9409
20110076261
2011-03-31

Antifungal Drug Delivery System

#9410
20110076249
2011-03-31

IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS

#9411
20110076233
2011-03-31

Delivery system for cytotoxic drugs by bispecific antibody pretargeting

#9412
20110076232
2011-03-31

SPECIFIC BINDING PROTEINS AND USES THEREOF

#9413
20110071612
2011-03-24

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

#9414
20110071226
2011-03-24

EMOLLIENT COMPOSITION

#9415
20110071193
2011-03-24

Spot-on pesticide composition

#9416
20110071176
2011-03-24

PHARMACEUTICAL COMPOSITION COMPRISING OMEGA-3 FATTY ACID AND HYDROXY-DERIVATIVE OF A STATIN AND METHODS OF USING SAME

#9417
20110071166
2011-03-24

Medicine consisting of concomitant use or combination of DPP-IV inhibitor and other diabetic medicine

#9418
20110071138
2011-03-24

Pharmaceutical composition for the treatment of premature ejaculation

#9419
20110071135
2011-03-24

Method and composition for treating alzheimer-type dementia

#9420
20110071122
2011-03-24

System for use by compounding pharmacists cists to produce hormone replacement medicine customized for each customer

#9421
20110071117
2011-03-24

COMBINATIONS OF ANTIOXIDANTS AND ANTI-INFLAMMATORY DRUGS IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE

#9422
20110071111
2011-03-24

CICLETANINE IN COMBINATION WITH ORAL ANTIDIABETIC AND/OR BLOOD LIPID-LOWERING AGENTS AS A COMBINATION THERAPY FOR DIABETES AND METABOLIC SYNDROME

#9423
20110071106
2011-03-24

Glycosaminoglycan oral use and compositions

#9424
20110071103
2011-03-24

METHODS OF TREATING HEPATIC ENCEPHALOPATHY

#9425
20110071100
2011-03-24

SULFOBETAINES FOR CANCER, OBESITY, MACULAR DEGENERATION, NEURODEGENERATIVE DISEASES

#9426
20110071098
2011-03-24

Flurbiprofen and muscle relaxant gel combinations thereof

#9427
20110071088
2011-03-24

Method for treating stroke via administration of NEP1-40 and inosine

#9428
20110071081
2011-03-24

Methods useful in the treatment of bone resorption diseases

#9429
20110071075
2011-03-24

PROMOTER FOR BICARBONATE SECRETION IN GASTROINTESTINAL TRACT

#9430
20110070613
2011-03-24

Monoclonal Antibody

#9431
20110070575
2011-03-24

Immunomodulatory Compositions, Combinations and Methods

#9432
20110070319
2011-03-24

BIFEPRUNOX DOSES FOR TREATING SCHIZOPHRENIA

#9433
20110070316
2011-03-24

Antimicrobial compositions containing synergistic combinations of quaternary ammonium compounds and essential oils and/or constituents thereof

#9434
20110070314
2011-03-24

METHODS FOR TREATING BRAIN TUMORS

#9435
20110070306
2011-03-24

Antimicrobial nanoemulsion compositions and methods

#9436
20110070274
2011-03-24

Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide

#9437
20110070269
2011-03-24

LIPOPOLYSACCHARIDE ISOLATED FROM PYRULARIA TISSUE AND/OR PYRULARIA-ASSOCIATED BACTERIA AND USES THEREOF

#9438
20110070258
2011-03-24

METHOD OF SLOWING THE AGING PROCESS BY ACTIVATING SIRTUIN ENZYMES

#9439
20110070250
2011-03-24

Therapeutical composition containing dentritic cells and use thereof

#9440
20110070241
2011-03-24

METHODS FOR MODULATING IMMUNE RESPONSES TO AAV GENE THERAPY VECTORS

#9441
20110070233
2011-03-24

ACTRIIB ANTAGONISTS AND DOSING AND USES THEREOF

#9442
20110070232
2011-03-24

Combination Therapy with an Antitumor Alkaloid

#9443
20110070222
2011-03-24

Therapeutic modulation of ocular surface lubrication

#9444
20110070216
2011-03-24

THERAPEUTIC COMBINATION COMPRISING A PULMONARY SURFACTANT AND ANTIOXIDANT ENZYMES

#9445
20110070209
2011-03-24

Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs

#9446
20110070200
2011-03-24

Abrogating proinflammatory cytokine production during oncolytic reovirus therapy

#9447
20110070198
2011-03-24

Antibacterial having an extract of pomegranate combined with hydrogen peroxide

#9448
20110070167
2011-03-24

METHOD OF PREVENTING FIBRIN CLOTS IN PULMONARY TISSUE THROUGH THE USE OF AEROSOLIZED ANTICOAGULANTS

#9449
20110070159
2011-03-24

Compositions comprising red microalgae polysaccharides and metals

#9450
20110070156
2011-03-24

Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy

#9451
20110070155
2011-03-24

Anti-CD74 immunoconjugates and methods

#9452
20110066251
2011-03-17

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

#9453
20110066242
2011-03-17

Biomimmetic nanofiber scaffold for soft tissue and soft tissue-to-bone repair, augmentation and replacement

#9454
20110065902
2011-03-17

High affinity human antibodies to PCSK9

#9455
20110065806
2011-03-17

EMOLLIENT COMPOSITION FOR THE PREVENTIVE TREATMENT OF ATOPIC DERMATITIS

#9456
20110065793
2011-03-17

HIGHLY PURIFIED ETHYL EPA AND OTHER EPA DERIVATIVES

#9457
20110065788
2011-03-17

AQUEOUS FORMULATIONS OF (2-HYDROXYMETHYL-INDANYL-4-OXY)-PHENYL-4,4,4-TRIFLUOROBUTANE-1-SULFONATE

#9458
20110065787
2011-03-17

Therapeutic agent for male sterility

#9459
20110065761
2011-03-17

Methods of treating nerve-related vision disorders by an insulinomimetic agent

#9460
20110065756
2011-03-17

METHODS AND COMPOSITIONS FOR TREATMENT OF OBESITY-RELATED DISEASES

#9461
20110065749
2011-03-17

METHOD AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF MENTAL DISORDERS

#9462
20110065744
2011-03-17

Method Of Inhibiting Mucin Secretion

#9463
20110065742
2011-03-17

Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments

#9464
20110065740
2011-03-17

Methods of treating travelers diarrhea and hepatic encephalopathy

#9465
20110065729
2011-03-17

Methods and compositions for ameliorating the undesirable effects of chemotherapy

#9466
20110065723
2011-03-17

COMPOSITIONS OF N-BENZYL-3-(4-CHLOROPHENYL)-2-[METHYL-[2-OXO-2-(3,4,5-TRIMETHOXYPHENYL)ACETYL]AMINO]-N-[3-(4-PYRIDYL)-1-[2-(4-PYRIDYL)ETHYL]PROPYL]PROPANAMIDE AND USES THEREOF

#9467
20110065721
2011-03-17

Metaxalone products, method of manufacture, and method of use

#9468
20110065691
2011-03-17

Therapeutic piperazines

#9469
20110065676
2011-03-17

COMBINATION THERAPIES COMPRISING PAR1 ANTAGONISTS WITH NAR AGONISTS

#9470
20110065674
2011-03-17

METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION

#9471
20110065664
2011-03-17

Kinase protein binding inhibitors

#9472
20110065663
2011-03-17

ANTI-CANCER COMBINATION THERAPY

#9473
20110065661
2011-03-17

PHARMACOPERONES FOR CORRECTING DISEASE STATES INVOLVING PROTEIN MISFOLDING

#9474
20110065659
2011-03-17

Protopanaxadiol-type ginsenoside compositions and uses thereof

#9475
20110065658
2011-03-17

Method for treating hyperuricemia employing an SGLT2 inhibitor and composition containing same

#9476
20110065657
2011-03-17

Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases

#9477
20110065655
2011-03-17

THERAPEUTIC COMPOSITION TO TREAT LESIONS CAUSED BY HERPES SIMPLEX VIRUS

#9478
20110065646
2011-03-17

Methods of reducing excitotoxicity-induced retinal ganglionic neuron degeneration by an orthodenticle HOMOLOG2 (OTX2) homeoprotein

#9479
20110065639
2011-03-17

Compositions and methods for visualizing and eliminating cancer stem cells

#9480
20110065636
2011-03-17

Screening and Therapy for Lymphatic Disorders Involving the FLT4 Receptor Tyrosine Kinase (VEGFR-3)

#9481
20110065630
2011-03-17

Use of a octreotide as a therapeutic agent

#9482
20110065628
2011-03-17

Medication Combinations for the Treatment of Alcoholism and Drug Addiction

#9483
20110065627
2011-03-17

Transdermal delivery of medicaments with combinations of cetylated fatty ester penetrant complexes

#9484
20110065174
2011-03-17

Hepatitis C virus codon optimized non-structural NS3/4A fusion gene

#9485
20110064835
2011-03-17

PROCESS FOR THE PREPARATION OF ACTIVE PRINCIPLES ON THERMAL WATER AND COMPOSITIONS COMPRISING THEM

#9486
20110064829
2011-03-17

Persistent and fast acting antiseptics and disinfectants based on calcium fluoride

#9487
20110064828
2011-03-17

TREATMENT OF METASTATIC TUMORS AND OTHER CONDITIONS

#9488
20110064826
2011-03-17

COMPOSITION FOR TREATING SKIN LESIONS

#9489
20110064823
2011-03-17

Transdermal delivery apparatus and method

#9490
20110064814
2011-03-17

Stable pharmaceutical products

#9491
20110064813
2011-03-17

USE OF SALSALATE WITH OR WITHOUT CAFFEINE AND WITH OR WITHOUT OMEGA 3, AND OTHER PHARMACEUTICAL COMPOUNDS IN A DISTINCTIVELY UNIQUE NANO-PARTICULATE CAPSULE AND TABLET

#9492
20110064811
2011-03-17

Solid forms of N-[2,4-BIS(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

#9493
20110064804
2011-03-17

Methods and compositions for the treatment of CNS-related conditions

#9494
20110064789
2011-03-17

DOCOSAHEXANOIC ACID AS INHIBITOR OF H. PYLORI

#9495
20110064787
2011-03-17

Detoxifying patch

#9496
20110064773
2011-03-17

PHARMACEUTICAL COMPOSITIONS COMPRISING A THYROID HORMON AND THEIR THERAPEUTIC USE

#9497
20110064771
2011-03-17

Plant extracts and uses thereof

#9498
20110064750
2011-03-17

METHOD AND KIT FOR TREATING NICOTINE ADDICTION

#9499
20110064749
2011-03-17

Compositions comprising immunoreactive reagents and saponins, and methods of use thereof

#9500
20110064748
2011-03-17

Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor

#9501
20110064747
2011-03-17

METHODS FOR TREATMENT OF A SARCOMA USING AN EPIMETABOLIC SHIFTER (COENZYME Q10)

#9502
20110064746
2011-03-17

Treatment of drug-related side effect and tissue damage by targeting the CD24-HMGB1-Siglec10 axis

#9503
20110064735
2011-03-17

METHODS FOR TREATING LYMPHOMAS IN CERTAIN PATIENT POPULATIONS AND SCREENING PATIENTS FOR SAID THERAPY

#9504
20110064720
2011-03-17

Dietary Supplement Compositions and Methods of Making and Using the Same

#9505
20110064712
2011-03-17

Dietary Supplement Compositions and Methods of Making and Using the Same

#9506
20110064711
2011-03-17

COMPOSITIONS CONTAINING COENZYME Q-10 AND AN ANTIOXIDANT

#9507
20110064708
2011-03-17

Methods and compositions for the dietary management of autoimmune disorders

#9508
20110064707
2011-03-17

PROBIOTICS TO IMPROVE GUT MICROBIOTA

#9509
20110064706
2011-03-17

METHOD OF PREVENTING, CONTROLLING AND AMELIORATING URINARY TRACT INFECTIONS AND SUPPORTING DIGESTIVE HEALTH BY USING A SYNERGISTIC CRANBERRY DERIVATIVE, A D-MANNOSE COMPOSITION AND A PROPRIETARY PROBIOTIC BLEND

#9510
20110064703
2011-03-17

Bone substitute compositions, methods of preparation and clinical applications

#9511
20110064702
2011-03-17

Methods and Kits for Enhancing Cell Survival, Stimulating Cell Proliferation, Treating Diabetic Patients, and/or Reinnervation

#9512
20110064696
2011-03-17

Hepatitis C virus inhibitors

#9513
20110064695
2011-03-17

Hepatitis C virus inhibitors

#9514
20110064694
2011-03-17

ANTI-HEPATITIS C ACTIVITY OF MESO-TETRAKIS-PORPHYRIN ANALOGUES

#9515
20110064689
2011-03-17

IN SITU IMMUNIZATION

#9516
20110064677
2011-03-17

Lipoxin analogs and methods for the treatment of periodontal disease

#9517
20110064676
2011-03-17

Diagnostic and therapeutic nanoparticles

#9518
20110064669
2011-03-17

USE OF GALANIN IN A METHOD OF TREATING NEURODEGENERATIVE DISEASES OR CONDITIONS

#9519
20110064665
2011-03-17

Diagnostic and therapeutic nanoparticles

#9520
20110064657
2011-03-17

Labeled inhibitors of prostate specific membrane antigen (PSMA), biological evaluation, and use as imaging agents

#9521
20110064654
2011-03-17

Prostate cancer diagnosis and treatment

#9522
20110064653
2011-03-17

Class I anti-CEA antibodies and uses thereof

#9523
20110064650
2011-03-17

MICROORGANISMS FOR PREVENTING AND TREATING NEOPLASMS ACCOMPANYING CELLULAR THERAPY

#9524
20110061651
2011-03-17

Formoterol superfine formulation

#9525
20110060412
2011-03-10

Tissue Engineered Meniscus Repair Composition

#9526
20110060295
2011-03-10

Method of reducing infections and/or air embolisms associated with vascular access procedures

#9527
20110060267
2011-03-10

ULTRAVIOLET IRRADIATION TO TREAT CORNEAL WEAKNESS DISORDERS

#9528
20110060259
2011-03-10

Gas mist pressure bath system

#9529
20110060164
2011-03-10

Method for the preparation of 4-fluoro-α-[2-methyl-1-oxopropyl]-γ-oxo-N-β-diphenylbenzenebutanamide and products therefrom

#9530
20110060120
2011-03-10

IMMUNOGENIC TREATMENT OF CANCER BY PEPTIDES INDUCING THE PLASMA MEMBRANE EXPOSURE OF ERP57

#9531
20110060049
2011-03-10

Derivatives of N-(arylamino) sulfonamides including polymorphs as inhibitors of MEK as well as compositions, methods of use and methods for preparing the same

#9532
20110060044
2011-03-10

ALIPHATIC ACID-CONTAINING N-HALOGENATED AMINO ACID FORMULATIONS

#9533
20110060042
2011-03-10

External preparation for skin

#9534
20110060037
2011-03-10

USE OF NPY Y5 RECEPTOR ANTAGONISTS FOR THE PREVENTION OF PSYCHO-STIMULANT AND OPIOID ABUSE

#9535
20110060028
2011-03-10

COMBINATION THERAPY

#9536
20110060021
2011-03-10

HISTONE DEACETYLASE INHIBITORS AND USES THEREOF

#9537
20110060005
2011-03-10

TREATMENT OF MITOCHONDRIAL DISORDERS USING A FARNESYL TRANSFERASE INHIBITOR

#9538
20110059998
2011-03-10

KIT, COMPOSITION, PRODUCT OR MEDICAMENT FOR TREATING COGNITIVE IMPAIRMENT

#9539
20110059962
2011-03-10

TRANSCRIPTION FACTOR MODULATING COMPOUNDS AND METHODS OF USE THEREOF

#9540
20110059930
2011-03-10

Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof

#9541
20110059928
2011-03-10

Graduated estrogen contraceptive

#9542
20110059927
2011-03-10

Calcium Formate For Use As A Dietary Supplement

#9543
20110059918
2011-03-10

Stable hyaluronan/steroid formulation

#9544
20110059917
2011-03-10

Vitamin D3 and analogs thereof for treating alopecia

#9545
20110059912
2011-03-10

Combination therapy comprising SGLT inhibitors and DPP4 inhibitors

#9546
20110059909
2011-03-10

METHODS FOR TREATING INFLAMMATORY DISORDERS

#9547
20110059906
2011-03-10

Energy status of an individual by enhanced production of an endogenous fuel source

#9548
20110059902
2011-03-10

Compositions for treating dry eye disease

#9549
20110059894
2011-03-10

Factor VII Polypeptides for Preventing Formation of Inhibitors in Subjects with Haemophilia

#9550
20110059891
2011-03-10

Alpha-MSH therapies for treatment of autoimmune disease

#9551
20110059886
2011-03-10

HCV NS3-NS4A Protease Inhibition

#9552
20110059192
2011-03-10

Methods and compositions for modulating hair growth or regrowth

#9553
20110059189
2011-03-10

METHOD AND COMPOSITION FOR TREATING CANCER, EFFECTING APOPTOSIS AND TREATING RETROVIRAL INFECTIONS

#9554
20110059186
2011-03-10

CANCER STEM CELL-TARGETED AND DRUG RESISTANT CANCER THERAPY

#9555
20110059174
2011-03-10

PKCdelta REGULATES NEUROINFLAMMATORY EVENTS

#9556
20110059171
2011-03-10

ORAL GALENIC FORMULATION INCLUDING KETOROLAC AND B-COMPLEX VITAMINS, IN WHICH VITAMIN B6 IS IN AN OUTER LAYER SEPARATED FROM THE REST OF THE ACTIVE PRINCIPLES

#9557
20110059170
2011-03-10

Methods for administering weight loss medications

#9558
20110059162
2011-03-10

Tannin-chitosan composites

#9559
20110059158
2011-03-10

CHARGED PHOSPHOLIPID COMPOSITIONS AND METHODS FOR THEIR USE

#9560
20110059136
2011-03-10

Methods and compositions for treating inflammatory bowel disease

#9561
20110059125
2011-03-10

ZWITTERIONIC IMMUNOMODULATORS FOR THE TREATMENT OF ASTHMA AND ALLERGY

#9562
20110059114
2011-03-10

Compositions and Methods for the Treatment of Radioresistant Glioma Stem Cells

#9563
20110059104
2011-03-10

Apo-2L receptor agonist and CPT-11 synergism

#9564
20110059081
2011-03-10

METHODS AND COMPOSITIONS FOR THE TREATMENT OF RECEPTOR TYROSINE KINASE MEDIATED DISEASES OR DISORDERS

#9565
20110059070
2011-03-10

Combination therapy for tumoral desease treatment

#9566
20110059062
2011-03-10

USE OF HYDROLYTIC AND OXIDATIVE ENZYMES TO DISSOLVE BIOFILM IN AIRWAY PASSAGES

#9567
20110059049
2011-03-10

Poxviral oncolytic vectors

#9568
20110059047
2011-03-10

NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#9569
20110059045
2011-03-10

PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT

#9570
20110059031
2011-03-10

Oral Cereal Beta Glucan Compositions

#9571
20110059026
2011-03-10

PHARMACEUTICAL DOSAGE FORM BEARING PREGNANCY-FRIENDLY INDICIA

#9572
20110054153
2011-03-03

METHOD OF PURIFYING APO-2 LIGAND/TRAIL USIN CRYSTALLISATION THE COLD

#9573
20110054036
2011-03-03

Composition and method for irrigation of a prepared dental root canal

#9574
20110054035
2011-03-03

Combination Comprising Combretastatin and Anticancer Agents

#9575
20110054033
2011-03-03

METHODS OF USING ABSCISIC ACID FOR AMELIORATING HYPERTENSION AND VASCULAR INFLAMMATION

#9576
20110054030
2011-03-03

USE OF EICOSAPENTAENOIC ACID AND/OR DOCOSAHEXAHENOIC ACID IN WOMEN WITH ENDOMETRIOSIS

#9577
20110054028
2011-03-03

SUPPLEMENT FOR REDUCING HIV TRANSMISSION AND METHOD THEREOF

#9578
20110054023
2011-03-03

Inhibition of HIF-1 activation for anti-tumor and anti-inflammatory responses

#9579
20110054006
2011-03-03

REGULATION OF ONCOGENES BY MICRORNAS

#9580
20110053991
2011-03-03

Treatment of Histone Deacetylase Mediated Disorders

#9581
20110053989
2011-03-03

Methods and materials for treating orthostatic hypotension or postural tachycardia syndrome

#9582
20110053986
2011-03-03

Respiratory disease treatment

#9583
20110053981
2011-03-03

Methods and Compositions Using Cholinesterase Inhibitors

#9584
20110053970
2011-03-03

Spirocyclic cyclohexane compounds useful to treat substance dependency

#9585
20110053960
2011-03-03

Method for treating pain syndrome and other disorders

#9586
20110053914
2011-03-03

Pharmaceutical Combination Comprising 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol or 6-Dimethylaminomethyl-1-(3-hydroxy-phenyl)-cyclohexane-1,3-diol and an Antiepileptic

#9587
20110053903
2011-03-03

PHARMACEUTICAL COMPOSITIONS BASED ON AZETIDINE DERIVATIVES

#9588
20110053900
2011-03-03

PROGESTERONE ANTAGONISTS SUCH AS CDB-4124 IN THE TREATMENT OF BREAST CANCER

#9589
20110053898
2011-03-03

TOPICAL COMPOSITION COMPRISING VITAMIN D ANALOGUE AND CORTICOSTEROIDS

#9590
20110053884
2011-03-03

POTENT COMBINATIONS OF ZIDOVUDINE AND DRUGS THAT SELECT FOR THE K65R MUTATION IN THE HIV POLYMERASE

#9591
20110053880
2011-03-03

Composition for treatment of tuberculosis

#9592
20110053879
2011-03-03

PICOPLATIN AND AMRUBICIN TO TREAT LUNG CANCER

#9593
20110053866
2011-03-03

PHARMACEUTICAL COMPOSITIONS

#9594
20110053863
2011-03-03

METHODS OF USING FLT3-LIGAND IN THE TREATMENT OF CANCER

#9595
20110053853
2011-03-03

Use of copolymer 1 for treatment of muscular dystrophy

#9596
20110053847
2011-03-03

Methods of treating vasodilatory shock

#9597
20110053839
2011-03-03

GLP-1 Derivatives II

#9598
20110053830
2011-03-03

METHODS FOR TREATING SEPTIC SHOCK

#9599
20110053240
2011-03-03

DNA DAMAGING AGENTS IN COMBINATION WITH TYROSINE KINASE INHIBITORS

#9600
20110052740
2011-03-03

Skin Circulation-Improving Agent And Skin Temperature-Elevating Agent